Education ▼

PER is hosting the 2nd Annual International Congress on Oncology Pathology^™ | June 23rd in NYC Hematologic Malignancies Medical Crossfire in NYC on July 14th! Register today!

SPECIALTY TOPICS

CURRENTLY VIEWING
Gynecologic Oncology

Gastrointestinal Cancer

Gynecologic Oncology

Singh Discusses Developments in Uterine Sarcoma

Arun S. Singh, MD, discusses current and emerging treatment strategies for patients with uterine leiomyosarcoma and other sarcomas.
Read More >>

FDA Approves Bevacizumab as Frontline Ovarian Cancer Treatment After Surgery

FDA Approves Pembrolizumab for PD-L1+ Cervical Cancer

ASCO 2018: Matched Targeted Therapy Extends Survival in Advanced Hard-to-Treat Cancers

Wingo Weighs in on Surgical Approaches in Ovarian Cancer

Treatment Approaches Evolving in Recurrent Ovarian Cancer

View More Stories >>

View Conference Coverage

2018 World Congress on GI Cancer

2018 European Hematology Association Congress

2018 State of the Science Summit on Genitourinary Cancers

2018 ASCO Annual Meeting

2018 ASPHO Conference

Dr. Glaspy on Immunotherapy in Endometrial Cancer

Dr. Wingo on the Evolution of Surgery in Endometrial Cancer

Dr. Tewari on Trial With Cemiplimab in Recurrent or Metastatic Cervical Cancer

Dr. Monk on the FDA Approval of Pembrolizumab in Cervical Cancer

Dr. Cohen Discusses Surgery in Early-Stage Ovarian Cancer

Dr. O'Malley on the FORWARD II Phase Ib Study in Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Ovarian Cancer Patients in the Future

Therapy Selection in BRCA-Mutated Ovarian Cancer

Sequencing Therapies in Ovarian Cancer

PARP Inhibitor Selection in Ovarian Cancer

Additional Considerations: PARPs for EOC in Practice

PARP Inhibitors in Recurrent Ovarian Cancer

Secondary Debulking in Recurrent Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Future Role of PARP Inhibition in Ovarian Cancer

Combinations With PARP Inhibitors for Ovarian Cancer

Ovarian Cancer: Selecting an Appropriate PARP Inhibitor

Ovarian Cancer: Treating Through Multiple Progressions

Ovarian Cancer: Comparisons Between PARP Inhibitors

Ovarian Cancer: Deciding Among PARP Inhibitors

Ovarian Cancer: Optimizing Treatment With Niraparib

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers

This discussion, led by James Tate Thigpen, MD, features the most recent information pertaining to treatment of gynecologic malignancies. The expert panel, Robert L. Coleman, MD, FACOG, FACS; Thomas Herzog, MD; Bradley J. Monk, MD, FACOG, FACS; and Angeles Alvarez Secord, MD, review the research and how to apply it in practice.View Now

Challenges for the Future of Gynecologic Cancers

Panelists provide their perspectives on the key challenges facing the future of ovarian and cervical cancer treatment.View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in Cervical Cancer, Ovarian Cancer, and CLL, and More